AzTrials
AzTrials

Anterior Cruciate Ligament InjuryNCT03141801

Blood Flow Restriction to Improve Muscle Strength After ACL Injury

A study testing DELFI PTS Personalized Tourniquet System for Blood Flow Restriction Training, Eccentric Exercise with BLAST Leg Press System and Concentric Exercise with BLAST Leg Press System in people with Anterior Cruciate Ligament Injury, run by University of Michigan at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Quadriceps muscle weakness is a common consequence following anterior cruciate ligament (ACL) injury and reconstruction. Maximizing quadriceps strength following ACL injury is significant as diminished quadriceps strength has been linked to the osteoarthritis that affects over 50% of surgically reconstructed limbs. Read more about this study

Who is it for?
Ages 14 to 30 years
Conditions the study is for
Anterior Cruciate Ligament Injury
What is being tested?
DELFI PTS Personalized Tourniquet System for Blood Flow Restriction Training, Eccentric Exercise with BLAST Leg Press System and Concentric Exercise with BLAST Leg Press System
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteUnited States
Study dates
25 Aug 2016to 21 Nov 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 30 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • suffered an acute, complete ACL rupture as confirmed by MRI
  • scheduled to undergo ACL reconstruction
  • scheduled to undergo ACL reconstruction with a surgeon affiliated with MedSport (University of Michigan Orthopaedic Clinic)
  • willing to undergo rehabilitation through MedSport (University of Michigan Orthopaedic Clinic) 5)) Willingness to participate in testing and follow-up as outlined in the protocol
  • 6) English-speaking

Who cannot join

  • inability to provide written informed consent (or assent)
  • female subjects who are pregnant or are planning to become pregnant during the study timeframe
  • previous ACL injury
  • previous surgery to either knee
  • bony fracture accompanying ACL injury
  • chronic ACL injuries (for our study, this is defined as patient reporting to a physician greater than 2 weeks after initial injury)
Show all 15Show fewer
  • patients who experienced a knee dislocation
  • History of blood clots
  • Previous deep vein thrombosis
  • Use of estrogen or progestin contraceptive
  • History of cerebrovascular disease
  • History of peripheral vascular disease
  • History of Sickle Cell Anemia
  • History of chronic muscular disorder (e.g. fibromyalgia)
  • History of severe hypertension

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Michigan

    Ann Arbor, Michigan, 48109

Other trials in United States

About this study

Official title: Blood Flow Restriction Training to Improve Muscle Strength and Function Following Anterior Cruciate Ligament Injury

Quadriceps muscle weakness is a common consequence following anterior cruciate ligament (ACL) injury and reconstruction. Maximizing quadriceps strength following ACL injury is significant as diminished quadriceps strength has been linked to the osteoarthritis that affects over 50% of surgically reconstructed limbs. Given that knee joint health following ACL injury is predicated on restoring quadriceps strength, identifying treatment approaches capable of improving strength is paramount. Blood flow restriction training (BFRT) is a method where oxygen to the muscle is intentionally reduced during exercise/rehabilitation and may lead to more timely and substantial strength gains. In the proposed project, we will examine the efficacy of BFRT in patients who have undergone ACL reconstruction and suffer from substantial quadriceps weakness.

Read the detailed description

Quadriceps muscle weakness is a common consequence following anterior cruciate ligament (ACL) injury and reconstruction. Maximizing quadriceps strength following ACL injury is significant as diminished quadriceps strength has been linked to the osteoarthritis that affects over 50% of surgically reconstructed limbs. Given that knee joint health following ACL injury is predicated on restoring quadriceps strength, identifying treatment approaches capable of improving strength is paramount. Blood flow restriction training (BFRT) is a method whereby oxygen to the muscle is intentionally reduced during exercise/rehabilitation and may lead to more timely and substantial strength gains. In the proposed project, we will examine the efficacy of BFRT in patients who have undergone ACL reconstruction and suffer from quadriceps weakness. This project will have a randomized clinical trial design. Sixty patients that have torn their ACL and plan to undergo surgical reconstruction will be randomized into one of four groups: 1) eccentric exercise; 2) concentric exercise; 3) eccentric exercise with blood flow restriction; or 4) concentric exercise with blood flow restriction. All patients regardless of randomization assignment will also receive standard of care ACL rehabilitation. Approximately 6 weeks after ACL reconstruction surgery, patients will begin to receive the study interventions which will last for 8 weeks. The concentric exercise will be a leg press exercise done on a conventional leg press machine, while the eccentric exercise will be a leg press exercise done on a device designed to elicit eccentric muscle contractions. Patients will train at 70% of their 1 repetition maximum and will complete 4 sets of 10 contractions at each session (2 sessions/week). For patients randomized to the BFRT groups they will complete the leg press exercise while blood flow the the quadriceps muscle is restricted with a BFRT device (Delfi Personalized Tourniquet System for Blood Flow Restriction). We will quantify our dependent variables prior to surgical reconstruction, 6 weeks post-operatively (before study intervention starts), 14 weeks post-operatively (immediately after study intervention ends), and time of physician discharge from rehabilitation (e.g. time medical clearance for return to activity). The primary outcome is isokinetic quadriceps strength. We hypothesize that patients who complete eccentric exercise along with blood flow restriction training will realize the greatest gains in muscle strength.

The DELFI PTS Personalized Tourniquet system is exempt from premarket notification and is therefore not subject to 510(k)

Being tested
DELFI PTS Personalized Tourniquet System for Blood Flow Restriction Training, Eccentric Exercise with BLAST Leg Press System, Concentric Exercise with BLAST Leg Press System
Keywords
ACL, Knee, Muscle
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DELFI PTS Personalized Tourniquet System for Blood Flow Restriction TrainingDevice

    Also called Kaatsu Training

    cuff is inflated to 80% of an individuals limb occlusion pressure

  • Eccentric Exercise with BLAST Leg Press SystemOther

    4 sets of 10 repetitions of an eccentric leg press exercise performed at 70% of the 1 repetition maximum

  • Concentric Exercise with BLAST Leg Press SystemOther

    4 sets of 10 repetitions of an concentric leg press exercise performed at 70% of the 1 repetition maximum

Study groups in NCT03141801
Study groupRoleWhat they receive
Eccentric Exercise with Delfi Blood Flow Restriction TrainingExperimentalPatients randomized to the eccentric exercise + blood flow restriction training group will receive eccentric exercise two times per week for 8 weeks, beginning 8-12 weeks after anterior cruciate ligament reconstruction. Patients will completed the exercise with knee range of motion limited to 20-60 degrees of knee flexion and will train at an intensity equal to 70% of their eccentric 1-repetition maximum for 4 sets of 10 repetitions. During exercise, patients will have the DELFI personalized tourniquet system applied over the quadriceps to restrict blood flow. The tourniquet will be set to a limb occlusion pressure of 80%.
Receives: Device: DELFI PTS Personalized Tourniquet System for Blood Flow Restriction Training; Other: Eccentric Exercise with BLAST Leg Press System
Concentric Exercise with Delfi Blood Flow Restriction TrainingExperimentalPatients randomized to the concentric exercise group will receive concentric exercise two times per week for 8 weeks, beginning 8-12 weeks after anterior cruciate ligament reconstruction. Patients will completed the exercise with knee range of motion limited to 20-60 degrees of knee flexion and will train at an intensity equal to 70% of their concentric 1-repetition maximum for 4 sets of 10 repetitions.
Receives: Device: DELFI PTS Personalized Tourniquet System for Blood Flow Restriction Training; Other: Concentric Exercise with BLAST Leg Press System
Eccentric ExerciseActive comparatorPatients randomized to the eccentric exercise group will receive eccentric exercise two times per week for 8 weeks, beginning 8-12 weeks after anterior cruciate ligament reconstruction. Patients will completed the exercise with knee range of motion limited to 20-60 degrees of knee flexion and will train at an intensity equal to 70% of their eccentric 1-repetition maximum for 4 sets of 10 repetitions.
Receives: Other: Eccentric Exercise with BLAST Leg Press System
Concentric ExerciseActive comparatorPatients randomized to the concentric exercise group will receive concentric exercise two times per week for 8 weeks, beginning 8-12 weeks after anterior cruciate ligament reconstruction. Patients will completed the exercise with knee range of motion limited to 20-60 degrees of knee flexion and will train at an intensity equal to 70% of their concentric 1-repetition maximum for 4 sets of 10 repetitions. During exercise, patients will have the DELFI personalized tourniquet system applied over the quadriceps to restrict blood flow. The tourniquet will be set to a limb occlusion pressure of 80%.
Receives: Other: Concentric Exercise with BLAST Leg Press System

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline to return to activity in quadriceps muscle strength

    concentric isokinetic muscle strength at 60 degrees per second

    Measured: Pre-surgery (baseline), Return to Activity (~9 months post-surgery)

Secondary outcomes (5)
  1. Knee Flexion Angle

    Peak knee flexion angle recorded during a single-legged hop (units: degrees)

    Measured: Return to Activity (~9 months post-surgery)

  2. Knee Flexion Moment

    Peak knee flexion moment recorded during a single-legged hop (units: Nm/kg)

    Measured: Return to Activity (~9 months post-surgery)

  3. Change from baseline to pre-intervention in PROMIS Global Health Scale

    Patient-reported outcome measured to assess health related quality of life. Physical Function Average: t score = 50±10 Min: 10 Max: 90

    Measured: Pre-surgery (baseline), Pre-intervention (~10 weeks post-surgery)

  4. Change from baseline to post-intervention in PROMIS Global Health Scale

    Patient-reported outcome measured to assess health related quality of life. Physical Function Average: t score = 50±10 Min: 10 Max: 90

    Measured: Pre-surgery (baseline), Post-intervention (~18 weeks post-surgery)

  5. Change from baseline to return to activity in PROMIS Global Health Scale

    Patient-reported outcome measured to assess health related quality of life. Physical Function Average: t score = 50±10 Min: 10 Max: 90

    Measured: Pre-surgery (baseline),Return to Activity (~9 months post-surgery)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2017
  2. Study start25 Aug 2016
  3. Primary completion21 Nov 2018
  4. Study completion21 Nov 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
48 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03141801
Sponsor's protocol ID
HUM00110455
Status last verified
Jan 2019
First submitted
17 Apr 2017
Last updated
23 Jan 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Curran MT, Bedi A, Mendias CL, Wojtys EM, Kujawa MV, Palmieri-Smith RM. Blood Flow Restriction Training Applied With High-Intensity Exercise Does Not Improve Quadriceps Muscle Function After Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial. Am J Sports Med. 2020 Mar;48(4):825-837. doi: 10.1177/0363546520904008.

    PubMed 32167837

Questions about this trial

What is this clinical trial studying?

A study testing DELFI PTS Personalized Tourniquet System for Blood Flow Restriction Training, Eccentric Exercise with BLAST Leg Press System and Concentric Exercise with BLAST Leg Press System in people with Anterior Cruciate Ligament Injury, run by University of Michigan at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline to return to activity in quadriceps muscle strength (time frame: Pre-surgery (baseline), Return to Activity (~9 months post-surgery)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03141801, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2019; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in